NEW YORK, NY / ACCESS Newswire / December 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Iron Mountain Incorporated ("Iron Mountain Incorporated") (NYSE:IRM) concerning possible violations of federal securities laws. On November 19, 2025, Gotham City Research published a report alleging that the company understates its leverage, inflates […]

(TSX-V:KNE),(Pinksheets:KNBIF),(PinkSheets:KNBIF), WINNIPEG, Manitoba, Dec. 10, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that Health Canada has approved its revyve(R) Antimicrobial Wound Gel Spray for use in Canada. Health Canada approved revyve Antimicrobial Wound Gel Spray revyve Antimicrobial Wound Gel Spray has been previously cleared under the

Kane Biotech Receives Health Canada Approval for revyve(R) Antimicrobial Wound Gel Spray GlobeNewswire December 10, 2025 WINNIPEG, Manitoba, Dec. 10, 2025 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE) (“Kane Biotech”, “Kane” or the “Company”) today announces that Health Canada has approved its revyve(R) Antimicrobial Wound Gel Spray for use in Canada. Health Canada approved revyve

NEW YORK, NY / ACCESS Newswire / December 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Nutanix, Inc. ("Nutanix, Inc.") (NASDAQ:NTNX) concerning possible violations of federal securities laws. On November 25, 2025, after the market closed, Nutanix published first quarter fiscal 2026 revenue results that landed at the

Socura, a UK-based cybersecurity services provider that protects many of the nation's biggest NHS trusts, councils, and private companies, has been certified by Great Place To Work®*. The certification follows an independent, anonymous survey of its employees, in which 97% said Socura is a great place to work – 43 percentage points higher than a

NEW YORK, NY / ACCESS Newswire / December 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Agios Pharmaceuticals, Inc. ("Agios Pharmaceuticals, Inc.") (NASDAQ:AGIO) concerning possible violations of federal securities laws. On November 19, 2025, Agios reported topline results from its RISE UP Phase 3 trial of Mitapivat in

New York, New York–(Newsfile Corp. – December 10, 2025) – Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations

New York, New York–(Newsfile Corp. – December 10, 2025) – Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations

New York, New York–(Newsfile Corp. – December 10, 2025) – Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company’s senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal

New York, New York–(Newsfile Corp. – December 10, 2025) – December 10, 2025) – Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Beyond Meat, Inc. (NASDAQ: BYND) for potential violations of the federal securities laws. If you invested in Beyond Meat, you are encouraged to obtain additional information by visiting: